Combined differentiating therapy for myelodysplastic syndromes: A phase II studyDario Ferrero, Alessandro Pileri, Patrizia Pregno et al.|Leukemia Research|1996Cited by 35
P104 Prognostic role of transfusion requirement in myelodysplastic syndromesFlavia Salvi, Alessandro Levis, Antonella Darbesio et al.|Leukemia Research|2007Cited by 1
P002 Clinical and epidemiological considerations on myelodysplastic syndromes (MDS). The experience of the Piedmont MDS RegisterDaniela Gioia, A. Levis, Daniela Cilloni et al.|Leukemia Research|2007Cited by 0
Phase II Multicenter Study of Association of Arsenic Trioxide (ATO) and Ascorbic Acid in Myelodysplastic Syndrome.Flavia Salvi, Alessandro Levis, Daniela Gioia et al.|Blood|2009Cited by 0